this Thank and In like I themes morning would you, remarks there to my cover. good three morning, are key everyone. Seth,
to stabilize very environment. to taken earnings offset of outside have difficult we in a action First, areas our control
the plan, annual by we the reformulation. established and strengthening As of dollar anticipated we oral our U.S. the to impacted have largely when Colgate-Gantrez related care been loss the
others, market in Now materials was and specifically, sunscreen by impacted products U.S. The unlike season sunscreen tariffs also XX% the products impacting and impact China. weakness of more negative recently, dynamics. new certain we Europe exported other out and been More our for demand the a export we competitiveness of trade have weak U.S. and into demand of tariffs the for
factors we also impacted formulations. ASIs approximately EBITDA that New impacted certain demand could have aggregate, the year-over-year. on In requirements China basis, by XX% year-to-date regulatory estimate preservative negatively these for a
this have meaningful In sales context, our More we nutraceuticals, action. Coatings and than the at market team taken or the has faster specifically, Pharma, in grown Nutrition.
and over basis on by we plant footprint by above also prices Ashland's improving and reliability FX-neutral raised system. cost reduced fixed SG&A we have reduced an raw have reducing year-to-date X% the spend implementation material production consolidating costs have with We of inflation, by and production and our
Ashland, a year, earnings have for year-to-date basis improvement margins on margins versus the we XX result while and is a essentially earlier what basis. And we prior Ingredients not EBITDA achieved adjusted flat expected point in year-to-date growth Specialty this EBITDA year net
levels actions periods. that and of portfolio Importantly, led evolution our much to than our demonstrate has these results lower prior in cyclicality
Ashland's to our a year EPS made have Second, date. same operating In by XXXX, 'XX adjusted adjusted our by The future. fiscal and impact on XX%. strategy we and year confident grew results XX% are our EBITDA in meaningful we fiscal levers
early very fiscal a year take beyond factors negative XXXX, we lessen look substantially. at the our should As control
short-term reformulation. FX exact And the terms to timing, believe, is market QX, impact Colgate the track and nature. negative We of current to we predict weakness are in on difficult largely while lap of in in
drive to to negative results and action new are improved related approval supply tariff cost More to launches, program lastly, our of gaining driving impacts, contracts year. strong end we plant the we aggressive share new including, chain the million our continue to adapting product for out regulations, offset impact in through the gain increase focus calendar in new importantly, response reformulating on $XXX by gains of achieving ingredient renegotiating make we reliability. taking products our lean manufacturing and as And full
Personal faced share the in preference as and consumer while an ultimately skills to this we to to ongoing picture enable changes customer back innovation Stepping we our leverage challenges perspective, opportunity trends our grow position. from partnering an Ashland in innovation view Care year, core and bigger regulatory
made to have is two resource significant size pipeline years. product new an increase last product impact new the our the over deployment changes in the result and We our sales. of process and of innovation The
note our mix additional meeting and redeploy are We important to and XX% additional activities actions, ASI a that committed focus remain volume currently cost instead focus pricing EBITDA new through working technical maintenance product resources leverage to business XX% to less margin actions of development. improvements, existing to It we is on on initiatives. targets, to also combination more productivity
the we Marl late business close anticipated. track summer this on Composites remain sale and as Thirdly, to
Maleic all $X.XXX discussions continued sale. retain The Maleic Ashland business be the will the billion, price including to the we of proceeds. sale agreement rights to with and Anhydride will adjusted announced INEOS business FTC, any from subsequent Following to an retention purchase the with exclude the
annual of facility consists Virginia and revenues Neal, Maleic The one of $XX West in million. approximately business generates
to shortly by late close work regulatory to preparations and track. transaction, the on We expect continue receiving remaining INEOS with transaction summer. the anticipate the remain divestiture and to close for approvals We
now commitment to X.X We transaction and repayment the for use following turns. close at the our about proceeds leverage of reduce expect roughly debt reduction estimated support the net $XXX in of to our continue to million to
So in for others, significant year. our had we expectations have growth had of summary, factors fiscal Like we this strong outside control.
less our market actions helping are than earnings stability. offset we Gains year-over-year We strategy. what is current the are from targeting while have action the are and operating result, implementing taken to our dynamics,
recovers growth, intend this complete We market a strong and and the when the we expect a We clear portfolio results. team earnings business, we sales year. to to summer, demand strategy likely on driving believe focused more return later have great to this and transformation a normalized
call Kevin turn now more for discussion the results. will over detailed a third to I our of quarter